Spontaneously hypertensive rat: cholera toxin converts suppression to immunity through a Th2 cell-IL-4 pathway

被引:3
作者
Pascual, DW
Coste, M
Boyaka, PN
Kiyono, H
McGhee, JR
机构
[1] UNIV ALABAMA, DEPT MICROBIOL, BIRMINGHAM, AL 35294 USA
[2] UNIV ALABAMA, DEPT ORAL BIOL, BIRMINGHAM, AL 35294 USA
[3] UNIV ALABAMA, IMMUNOBIOL VACCINE CTR, BIRMINGHAM, AL 35294 USA
[4] OSAKA UNIV, MICROBIAL DIS RES INST, DEPT MUCOSAL IMMUNOL, SUITA, OSAKA 565, JAPAN
关键词
T helper subsets; cytokines; interferon-gamma;
D O I
10.1152/ajpregu.1997.273.4.R1509
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The spontaneously hypertensive rat (SHR) exhibits a number of T cell dysfunctions that develop concurrently with elevated blood pressure. Studies have shown a mitogen-induced lymphocyte suppression mediated in part by the production of interferon-gamma (IFN-gamma), which stimulated NO production by macrophages. To assess whether this immune suppression is reversible, SHR were immunized with diphtheria toroid (DT) with or without cholera toxin (CT) as adjuvant. SHR immunized with DT only displayed weak serum immunoglobulin G (IgG) anti-DT titers, tenfold less than similarly treated normotensive Wistar-Kyoto rats (WKYR). SHR CD4(+) T cells failed to proliferate upon in vitro stimulation with DT. In contrast, SHR coimmunized with DT and CT showed serum IgG antibody titers similar to WKYR and Brown Norway rats. Coimmunization with CT rescued SHR CD4(+) T cells from suppression and supported DT or B subunit of CT-specific proliferative responses, and these cells produced more interleukin-4 (IL-4) than IFN-gamma, and anti-IFN-gamma antibody treatment enhanced IL-4 production. Exogenous IL-4 increased the proliferation of antigen-specific CD4(+) T cells, whereas IFN-gamma was inhibitory. This study shows that the adjuvant CT induces T helper 2-type responses, reversing the T cell dysfunction in the SHR.
引用
收藏
页码:R1509 / R1518
页数:10
相关论文
共 47 条
[1]  
BA D, 1982, J IMMUNOL, V128, P1211
[2]   The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts [J].
Binder, J ;
Lehmann, M ;
Graser, E ;
Hancock, WW ;
Watschinger, B ;
Onodera, K ;
Sayegh, MH ;
Volk, HD ;
KupiecWeglinski, JW .
TRANSPLANTATION, 1996, 61 (05) :804-811
[3]   EVOLUTION OF THE RAT IMMUNOGLOBULIN GAMMA HEAVY-CHAIN GENE FAMILY [J].
BRUGGEMANN, M .
GENE, 1988, 74 (02) :473-482
[4]  
COFFMAN RL, 1986, J IMMUNOL, V136, P4538
[5]   IMMUNE-MECHANISMS IN EXPERIMENTAL AND ESSENTIAL-HYPERTENSION [J].
DZIELAK, DJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (03) :R459-R467
[6]   RAISED SERUM IGG LEVELS IN HYPERTENSION [J].
EBRINGER, A ;
DOYLE, AE .
BMJ-BRITISH MEDICAL JOURNAL, 1970, 2 (5702) :146-+
[7]  
ELSON CO, 1984, J IMMUNOL, V133, P2892
[8]  
GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245
[9]   ABNORMAL IMMUNE FUNCTION IN MALIGNANT HYPERTENSION [J].
HILME, E ;
HANSSON, L ;
SANDBERG, L ;
SODERSTROM, T ;
HERLITZ, H .
JOURNAL OF HYPERTENSION, 1993, 11 (09) :989-994
[10]   OPTIMIZING ORAL VACCINES - INDUCTION OF SYSTEMIC AND MUCOSAL B-CELL AND ANTIBODY-RESPONSES TO TETANUS TOXOID BY USE OF CHOLERA-TOXIN AS AN ADJUVANT [J].
JACKSON, RJ ;
FUJIHASHI, K ;
XUAMANO, JC ;
KIYONO, H ;
ELSON, CO ;
MCGHEE, JR .
INFECTION AND IMMUNITY, 1993, 61 (10) :4272-4279